Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees108
Employees108
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees108
Employees108
NBTX Key Statistics
Market cap1.05B
Market cap1.05B
Price-Earnings ratio-26.90
Price-Earnings ratio-26.90
Dividend yield—
Dividend yield—
Average volume37.93K
Average volume37.93K
High today—
High today—
Low today—
Low today—
Open price$22.72
Open price$22.72
Volume0.00
Volume0.00
52 Week high$30.35
52 Week high$30.35
52 Week low$2.82
52 Week low$2.82
Stock Snapshot
As of today, Nanobiotix(NBTX) shares are valued at $21.44. The company's market cap stands at 1.05B, with a P/E ratio of -26.90.
On 2025-12-18, Nanobiotix(NBTX) stock opened at $22.72, reached a high of —, and a low of —.
The Nanobiotix(NBTX)'s current trading volume is 0, compared to an average daily volume of 37.93K.
In the last year, Nanobiotix(NBTX) shares hit a 52-week high of $30.35 and a 52-week low of $2.82.
In the last year, Nanobiotix(NBTX) shares hit a 52-week high of $30.35 and a 52-week low of $2.82.
NBTX News
TipRanks 16h
Nanobiotix Announces Share Capital and Voting Rights Update as of November 30, 2025Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%